Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-12-03

Clinical Trial Update: Effectiveness of Naltrexone Versus Placebo to Reduce Craving for Alcohol With Evaluation of Genetic Variability. [Phase 4]

View source ↗

Summary

A Phase 4 study compared naltrexone to placebo for reducing alcohol craving and evaluated genetic factors that may affect response in people with alcohol use di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naltrexone (Naltrexone)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Alcohol Dependence | Phase 4 | Status: COMPLETED | Results posted: 2012-12-03